← All articles

Best Exercise for Arterial Stiffness After Menopause

Combined aerobic and resistance training has the best evidence for lowering arterial stiffness after menopause—but timing, measurement, and genetics matter.

Combined training has the best case, with limits

For postmenopausal women aiming to improve arterial health, the best-supported exercise plan combines aerobic and resistance training. A 2024 systematic review by Ferreira et al. found that these programs produced the largest reported reductions in carotid-femoral pulse wave velocity (cfPWV), a common measure of central arterial stiffness. The strongest combined programs reduced cfPWV by as much as 2.6 m/s.

That is encouraging, but it is not a license to call every workout a vascular makeover. Across the review's 13 studies and roughly 700 postmenopausal women, only seven studies reported statistically significant improvement in arterial stiffness. Effective programs generally lasted 8 to 24 weeks and used three to five sessions per week. The results support consistent training, not a single heroic session followed by an intimate relationship with the couch.

Pulse wave velocity measures how quickly a pressure wave travels through an artery. Stiffer arteries transmit that wave faster. cfPWV is the preferred measure of central aortic stiffness, while brachial-ankle PWV (baPWV) captures a different, more peripheral path. They both matter, but they are not interchangeable. Mixing them freely can make modest evidence look more settled than it is.

Why arteries stiffen after menopause

Hormonal change likely contributes, but age remains a formidable confounder. In a cross-sectional study of 234 women ages 19 to 58, Laakkonen et al. found that sex hormone levels were inversely associated with arterial stiffness, with the association most pronounced around the menopausal transition. This supports a hormonal contribution; it does not prove that estrogen withdrawal alone causes the increase.

Arteries also change structurally with age. Elastin fragments, collagen cross-links accumulate, and calcification can develop in the arterial wall. A 2024 analysis by O'Neill et al. cautioned that chronological aging and menopause are hard to separate in studies of aortic stiffness. Without age-matched premenopausal control groups, researchers cannot assign a precise share of stiffening to menopause itself.

There are other biological pathways as well. Pauls et al. identified age-, menopause-, and obesity-related differences in oxylipins, bioactive lipid mediators linked to vascular health. Exercise may improve vascular function, but no exercise protocol in this evidence base has shown that it corrects every menopause-associated pathway.

What each exercise modality can—and cannot—claim

Ferreira and colleagues provide the most directly relevant comparison, although it is not a head-to-head trial that randomly assigned one postmenopausal cohort to every modality. Combined aerobic-plus-resistance programs had the largest cfPWV reductions, while aerobic-only programs—especially aquatic and swimming protocols—also produced significant reductions. Reported cfPWV improvements across successful programs ranged from 0.22 to 1.56 m/s, with the largest individual combined-training result reaching 2.6 m/s.

Resistance-only training, taekwondo, and flexibility programs produced inconsistent findings. That does not mean resistance training lacks value. It improves strength, function, bone-related outcomes, and may contribute to vascular adaptation alongside aerobic work. It means the available postmenopausal-specific evidence does not support resistance-only training as the primary strategy when arterial stiffness is the target.

Broader evidence points in the same direction without adding postmenopausal-specific precision. A 2026 systematic review by Shaw et al. concluded that aerobic and resistance exercise can reduce arterial stiffness in older adults through complementary pathways. A 2024 meta-analysis by Ho et al. also found aerobic exercise beneficial in older people. These studies strengthen the general case for exercise, but their populations were not limited to postmenopausal women.

Intensity remains unresolved. A 2025 systematic review and meta-analysis by Luo et al. compared high-intensity interval training with moderate-intensity continuous training in adults and did not establish a uniform winner for arterial stiffness. The practical implication is pleasantly unglamorous: choose an aerobic format you can perform consistently and combine it with progressive resistance training.

Do not measure PWV right after a hard workout

Exercise has opposite short- and long-term effects on PWV. The distinction is central.

In Zhou et al.'s 2022 acute-exercise study, postmenopausal women performed aquatic high-intensity intermittent jumping. Immediately afterward, baPWV increased by 4.3% to 20.8% across genotype groups. Intense exercise activates the sympathetic nervous system, raises mean arterial pressure, and increases arterial wall tension. Those acute hemodynamic changes can raise PWV without indicating structural deterioration of the artery.

Some recovery occurred over 30 to 120 minutes, and some protocols produced modest below-baseline values during recovery. Still, an immediate post-exercise PWV reading does not predict long-term training adaptation. Chronic reductions in stiffness emerge after weeks of repeated training; acute readings mostly capture the physiology of that moment.

Blood pressure patterns can further distort interpretation. Wali et al. reported that normotensive perimenopausal women can have non-dipping blood-pressure patterns and elevated maximum blood pressure associated with arterial stiffness. Because PWV responds to prevailing mean arterial pressure, exercise studies should standardize measurement timing and account for circadian blood-pressure variation. Otherwise, a lower PWV could partly reflect a different hemodynamic state rather than a remodeled arterial wall.

Nitric oxide matters, but supplement trials do not prove an exercise mechanism

Reduced nitric oxide (NO) availability is a plausible feature of postmenopausal vascular dysfunction. Two supplementation trials show that this pathway has clinical relevance. In a randomized trial of 25 hypertensive postmenopausal women, four weeks of 10 g/day L-citrulline increased serum L-arginine and improved flow-mediated dilation compared with placebo; it also improved some blood-pressure measures. The study was designed to assess endothelial function, aortic stiffness, and blood pressure, not exercise-induced adaptation. Read the details in Maharaj et al..

Likewise, a randomized, double-blind, placebo-controlled trial of 20 postmenopausal women ages 60 to 85 found that 12 weeks of nitrate-rich beetroot extract, providing 8.8 mmol/day of nitrate, reduced carotid stiffness measures versus nitrate-depleted extract. Pinheiro et al. tested dietary nitrate, not exercise.

Exercise is often proposed to improve NO signaling through shear stress and endothelial adaptation. That explanation is biologically plausible, but the available exercise trials in postmenopausal women do not directly establish it. Supplement results support the importance of NO biology; they do not prove that exercise works through the same pathway or that combining supplements with training improves outcomes.

ACE genotype testing is not ready for exercise prescriptions

Zhou et al. also examined the ACE insertion/deletion genotype. The DD subgroup contained only 12 participants, and the study had no non-exercise control group. DD carriers had higher resting systolic blood pressure and numerically different baPWV responses after the acute aquatic exercise bout. Those observations fit the hypothesis that the DD genotype may be associated with higher ACE activity and angiotensin II exposure.

A 12-person subgroup in one acute study can generate a useful question. It cannot tell a clinician or trainer which exercise program a woman should follow.

ACE testing therefore adds no actionable value for exercise selection in postmenopausal women. A larger trial would need prespecified genotype groups, a control condition, standardized PWV timing, and chronic training follow-up before genotype-guided recommendations become credible.

A practical, evidence-calibrated plan

Build a routine around combined aerobic and resistance exercise three to five times per week, sustained for at least 8 weeks. Aerobic training in water is a reasonable aerobic-only alternative when joint symptoms, access, or preference make land-based exercise less practical. Reduce sedentary time as well: a review by Williams et al. concluded that the full 24-hour movement pattern, including less sitting, contributes to vascular remodeling in older adults.

Use PWV, if available, as a standardized trend measure rather than a post-workout scorecard. Measure at the same time of day, after adequate recovery, and alongside blood pressure. The best available evidence supports combined training as a sensible arterial-health strategy. It does not show that every program works, that a specific PWV reduction guarantees fewer cardiovascular events, or that an ACE genotype test can personalize the prescription.

Comments

No comments yet. Be the first!